Geisinger Health System
Survey Suggests Polygenic Embryo Screening Has Higher Public Acceptance Than Anticipated
A national survey of more than 6,800 US participants asked about attitudes towards polygenic embryo screening, germline genome editing, and SAT prep courses.
While Geisinger sees value in identifying at-risk patients and diagnosing cancer early, some experts are concerned about overtreatment.
Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study
The Pennsylvania health system will be able to access patients in both urban and rural settings, aiding Freenome's goal to recruit a total of 8,000 individuals.
Rare Single-Gene Variants Confer High Risk for Mental Health Conditions, Geisinger Study Shows
Premium
Researchers suggest physicians should more routinely order genetic testing for patients with mental health disorders, a group that has historically been undertested.
Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk
The health system will partner with the NCI to look for new cancer risk variants in a large population biobank, in the hopes of improving screening and care.